86 related articles for article (PubMed ID: 3753866)
21. Dissociation of xanthine oxidase induction and cytochrome P450 depression during interferon induction in the rat.
Cribb AE; Renton KW
Biochem Pharmacol; 1993 Dec; 46(11):2114-7. PubMed ID: 7505583
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats.
Cha YN; Heine HS
Cancer Res; 1982 Jul; 42(7):2609-15. PubMed ID: 6805943
[TBL] [Abstract][Full Text] [Related]
23. The effects of an interferon inducer, polyriboinosinic polyribocytidylic acid on cytochrome P-450 dependent hepatic progesterone metabolism.
Wong JY; Lee EJ; Moochhala SM
Life Sci; 1993; 53(25):1893-901. PubMed ID: 8255150
[TBL] [Abstract][Full Text] [Related]
24. Selective depression of hepatic cytochrome P-450 hemoprotein by interferon inducers.
Zerkle TB; Wade AE; Ragland WL
Biochem Biophys Res Commun; 1980 Sep; 96(1):121-7. PubMed ID: 7437028
[No Abstract] [Full Text] [Related]
25. Dietary cholesterol-induced changes of xenobiotic metabolism in liver. II. Effects of phenobarbitone and carbon tetrachloride on activities of drug-metabolizing enzymes.
Hietanen E; Ahotupa M; Heikelä A; Laitinen M
Drug Nutr Interact; 1982; 1(4):313-27. PubMed ID: 6821390
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes.
Barnett CR; Abbott RA; Bailey CJ; Flatt PR; Ioannides C
Biochem Pharmacol; 1992 Apr; 43(8):1868-71. PubMed ID: 1575780
[TBL] [Abstract][Full Text] [Related]
27. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer poly rI.poly rC.
Morgan ET
Biochem Pharmacol; 1991 Jun; 42(1):51-7. PubMed ID: 2069598
[TBL] [Abstract][Full Text] [Related]
28. Effect of interferon inducing agents (polyriboinosinic acid . polyribocytidylic acid and tilorone) on the heme turnover of hepatic cytochrome P-450.
el Azhary R; Renton KW; Mannering GJ
Mol Pharmacol; 1980 May; 17(3):395-9. PubMed ID: 7393215
[No Abstract] [Full Text] [Related]
29. [Activity of enzymes of xenobiotic metabolism in the liver of rats after administration of polychlorinated biphenyls].
Tutel'ian VA; Lashneva NV; Sorokovaia GK; Kravchenko LV; Chichilanova GV; Ivanenko GF; Gadzhieva ZM
Gig Sanit; 1990 May; (5):20-3. PubMed ID: 2118877
[No Abstract] [Full Text] [Related]
30. Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver.
Steinberg P; Lafranconi WM; Wolf CR; Waxman DJ; Oesch F; Friedberg T
Mol Pharmacol; 1987 Oct; 32(4):463-70. PubMed ID: 3670281
[TBL] [Abstract][Full Text] [Related]
31. [Effects of the degree of fish oil oxidation on the state of xenobiotic metabolism enzymes].
Kravchenko LV; Kuz'mina EE; Avren'eva LI; Pozdniakov AL; Kulakova SN; Levachev MM
Vopr Pitan; 1994; (4):13-6. PubMed ID: 7817522
[TBL] [Abstract][Full Text] [Related]
32. Hepatic mixed-function oxidase system and microsomal lipid peroxidation in rats treated with a synthetic immunomodulator, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).
Yanev S; Zídek Z; Kadiiska M; Serbinova E; Masek K; Stoytchev T
Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):311-5. PubMed ID: 6748821
[TBL] [Abstract][Full Text] [Related]
33. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
Gunasena GH; Kanz MF
J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
[TBL] [Abstract][Full Text] [Related]
34. Piperine effects on the expression of P4502E1, P4502B and P4501A in rat.
Kang MH; Won SM; Park SS; Kim SG; Novak RF; Kim ND
Xenobiotica; 1994 Dec; 24(12):1195-204. PubMed ID: 7771106
[TBL] [Abstract][Full Text] [Related]
35. Effect of aluminum on the hepatic mixed function oxidase and drug metabolism.
Bidlack WR; Brown RC; Meskin MS; Lee TC; Klein GL
Drug Nutr Interact; 1987; 5(1):33-42. PubMed ID: 3105994
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms responsible for the thermal sensitivity of adrenal microsomal monooxygenases.
Colby HD; Johnson PB; Pope MR
Drug Metab Dispos; 1991; 19(3):679-82. PubMed ID: 1680636
[TBL] [Abstract][Full Text] [Related]
37. Characterization of dog hepatic drug-metabolizing enzymes and resultant effects on benzo[a]pyrene metabolite pattern and mutagenicity.
Golan MD; Bücker M; Schmassmann HU; Raphael D; Jung R; Bindel U; Brase HO; Tegtmeyer F; Friedberg T; Lorenz J; Stasiecki P; Oesch F
Drug Metab Dispos; 1980; 8(3):121-6. PubMed ID: 6104571
[No Abstract] [Full Text] [Related]
38. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
[TBL] [Abstract][Full Text] [Related]
39. Metabolism of benzo[a]pyrene by brain microsomes of fetal and adult rats and mice. Induction by 5,6 benzoflavone, comparison with liver and lung microsomal activities.
Rouet P; Alexandrov K; Markovits P; Frayssinet C; Dansette PM
Carcinogenesis; 1981; 2(9):919-26. PubMed ID: 6271416
[TBL] [Abstract][Full Text] [Related]
40. [Studies on correlation between liver drug metabolizing enzyme activities and microsomal membrane fluidity in phenobarbital treated rats].
Fu LS; Peng RX
Yao Xue Xue Bao; 1991; 26(8):567-71. PubMed ID: 1805518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
